Ève Dubé
Dr. Ève Dubé is a Canadian medical anthropologist based in Québec City, Québec. She is notable in the COVID-19 pandemic due to her position on the National Advisory Committee on Immunization (NACI).
Overview
Dubé is a researcher in the Scientific Group on Immunization at the Quebec National Institute of Public Health and is a researcher in the area of infectious and immune diseases at the CHU Sainte-Justine Research Center. She is also an invited professor in the Department of Anthropology at Laval University.1)
Her research focuses on social, cultural and ethical issues around infectious diseases prevention. Most of her research is related to vaccine hesitancy among patients and health care providers. She is the lead investigator of the Social Sciences and Humanities Network (SSHN) of the Canadian Immunization Research Network (CIRN). From 2013 to 2014, she was a member of the World Health Organization (WHO) working group on vaccine hesitancy and she is currently part of the WHO Global Advisory Committee on Vaccine Safety where she is mainly involved in vaccine risk communication.2)
History
Education
Dubé obtained her PhD in medical anthropology at Laval University.3)
Career
Quebec National Institute of Public Health
In 2008, Dubé joined the Scientific Group on Immunization at the Quebec National Institute of Public Health as a researcher.4)
World Health Organization
From 2012-2014, Dubé served on the World Health Organization working group on Vaccine Hesitancy.
Council of Canadian Academies
Dubé acted as a peer reviewer for a Council of Canadian Academies (CCA) report titled Fault Lines which analyzed “misinformation” and “disinformation” during the COVID-19 pandemic. The report was commissioned and paid for by the Government of Canada through Innovation, Science and Economic Development Canada (ISED).5)
Affiliations
Immunize Canada
Dubé is a member of Immunize Canada.6)
Pharmaceutical Companies
Dubé is a researcher at the Canadian Immunization Research Network (CIRN), which is partnered with GlaxoSmithKline, Pfizer and Sanofi.7)
Research
Vaccine Hesitancy
As part of her vaccine hesitancy research, Dubé published a paper on the “Tailoring Immunization Programmes (TIP)” approach developed by the World Health Organization Regional Office for Europe to increase vaccine uptake.8)
She conducted research in 2020, during which time she was working with NACI, on “false information” inhibiting a successful campaign with COVID-19 vaccines.9) She also studied willingness to accept a COVID-19 injection among children.10)
She also received funding from the European Union’s Horizon 2020 research and innovation program for a paper on vaccine hesitancy.11) Further funding has come from the French Ministry of Health.12)
Additional studies
1)
, 3)
Ève Dubé – Research Center. Université Laval. Retrieved April 9, 2022, from https://archive.ph/sEaHz
2)
Public Health Agency of Canada. (2022, February 25). National Advisory Committee on Immunization (NACI): Membership and representation. Government of Canada. https://web.archive.org/web/20220318105951/https://www.canada.ca/en/public-health/services/immunization/national-advisory-committee-on-immunization-naci/naci-membership-representation.html#fn1-rf
4)
Dr. Ève Dubé. (2014, October 23). CIRN | Canadian Immunization Research Network. https://archive.ph/shUG1
5)
Fault Lines. (2023, January 26). CCA Reports. https://web.archive.org/web/20230128035132/https://www.cca-reports.ca/reports/the-socioeconomic-impacts-of-health-and-science-misinformation/
6)
Final Program. (2016, December 6). Canadian Immunization Conference. https://web.archive.org/web/20220320171400/https://www.cpha.ca/sites/default/files/uploads/conferences/2021/cic16-final-program-en.pdf
7)
Partners. (2013, January 30). CIRN | Canadian Immunization Research Network. https://archive.ph/durb0
8)
Habersaat, K., MacDonald, N. E., & Ève Dubé, È. (2021). Designing tailored interventions to address barriers to vaccination. Canada Communicable Disease Report, 47(3), 166–169. https://doi.org/10.14745/ccdr.v47i03a07
9)
Rotolo, B., Dubé, E., Vivion, M., MacDonald, S. E., & Meyer, S. B. (2022). Hesitancy towards COVID-19 vaccines on social media in Canada. Vaccine. https://doi.org/10.1016/j.vaccine.2022.03.024
10)
McKinnon, B., Abalovi, K., Vandermorris, A., Dubé, È., Tuong Nguyen, C., Billou, N., Fortin, G., Parvez, M., Senga, J., Abou-malhab, J., Antoine Bellamy, M., Quach, C., & Zinszer, K. (2022). Using human-centred design to tackle COVID-19 vaccine hesitancy for children and youth: a protocol for a mixed-methods study in Montreal, Canada. BMJ Open, 12(4), e061908. https://doi.org/10.1136/bmjopen-2022-061908
11)
Verger, P., Botelho-Nevers, E., Garrison, A., Gagnon, D., Gagneur, A., Gagneux-Brunon, A., & Dubé, E. (2022). Vaccine hesitancy in health-care providers in Western countries: a narrative review. Expert Review of Vaccines, 1–19. https://doi.org/10.1080/14760584.2022.2056026
12)
Verger, P., Fressard, L., Soveri, A., Dauby, N., Fasce, A., Karlsson, L., Lewandowsky, S., Schmid, P., Dubé, E., & Gagneur, A. (2022). An instrument to measure psychosocial determinants of health care professionals’ vaccination behavior: Validation of the Pro-VC-Be questionnaire. Expert Review of Vaccines, 1–17. https://doi.org/10.1080/14760584.2022.2046467